Nancy E. Dempze’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.4M | Sell |
22,097
-13
| -0.1% | -$3.03K | 2.97% | 9 |
|
|
2025
Q4 | $4.58M | Buy |
22,110
+358
| +2% | +$70.8K | 2.38% | 15 |
|
|
2025
Q3 | $4.03M | Sell |
21,752
-418
| -2% | -$71.6K | 2.22% | 17 |
|
|
2025
Q2 | $3.39M | Sell |
22,170
-454
| -2% | -$69.8K | 1.95% | 22 |
|
|
2025
Q1 | $3.75M | Sell |
22,624
-2,462
| -10% | -$385K | 2.25% | 18 |
|
|
2024
Q4 | $3.63M | Sell |
25,086
-749
| -3% | -$116K | 2.1% | 18 |
|
|
2024
Q3 | $4.19M | Buy |
25,835
+401
| +2% | +$63.9K | 2.34% | 15 |
|
|
2024
Q2 | $3.72M | Buy |
25,434
+2,090
| +9% | +$311K | 2.55% | 17 |
|
|
2024
Q1 | $3.69M | Sell |
23,344
-109
| -0.5% | -$17.4K | 2.81% | 16 |
|
|
2023
Q4 | $3.68M | Buy |
23,453
+158
| +0.7% | +$24.2K | 3.07% | 13 |
|
|
2023
Q3 | $3.63M | Buy |
23,295
+155
| +0.7% | +$25.6K | 3.26% | 10 |
|
|
2023
Q2 | $3.83M | Buy |
23,140
+758
| +3% | +$122K | 3.28% | 9 |
|
|
2023
Q1 | $3.47M | Buy |
22,382
+610
| +3% | +$98.5K | 3.16% | 11 |
|
|
2022
Q4 | $3.85M | Buy |
21,772
+569
| +3% | +$98.2K | 3.75% | 6 |
|
|
2022
Q3 | $3.46M | Buy |
21,203
+490
| +2% | +$82.9K | 3.69% | 4 |
|
|
2022
Q2 | $3.68M | Sell |
20,713
-2,901
| -12% | -$517K | 3.69% | 5 |
|
|
2022
Q1 | $4.18M | Buy |
23,614
+888
| +4% | +$151K | 3.06% | 10 |
|
|
2021
Q4 | $3.89M | Buy |
22,726
+848
| +4% | +$139K | 2.62% | 13 |
|
|
2021
Q3 | $3.53M | Buy |
21,878
+415
| +2% | +$70.8K | 2.77% | 10 |
|
|
2021
Q2 | $3.54M | Sell |
21,463
-1,447
| -6% | -$240K | 2.98% | 10 |
|
|
2021
Q1 | $3.77M | Sell |
22,910
-402
| -2% | -$65K | 3.33% | 10 |
|
|
2020
Q4 | $3.67M | Buy |
23,312
+720
| +3% | +$106K | 3.37% | 8 |
|
|
2020
Q3 | $3.36M | Buy |
22,592
+1,685
| +8% | +$249K | 3.41% | 6 |
|
|
2020
Q2 | $2.94M | Buy |
20,907
+80
| +0.4% | +$11.7K | 3.28% | 9 |
|
|
2020
Q1 | $2.73M | Buy |
20,827
+1,451
| +7% | +$206K | 3.67% | 6 |
|
|
2019
Q4 | $2.83M | Buy |
19,376
+570
| +3% | +$77.3K | 3.13% | 11 |
|
|
2019
Q3 | $2.43M | Sell |
18,806
-1,445
| -7% | -$190K | 2.94% | 15 |
|
|
2019
Q2 | $2.82M | Sell |
20,251
-1,862
| -8% | -$258K | 3.24% | 10 |
|
|
2019
Q1 | $3.09M | Sell |
22,113
-415
| -2% | -$55.6K | 3.65% | 6 |
|
|
2018
Q4 | $2.91M | Sell |
22,528
-1,043
| -4% | -$145K | 4.04% | 3 |
|
|
2018
Q3 | $3.26M | Sell |
23,571
-156
| -0.7% | -$20.7K | 3.65% | 6 |
|
|
2018
Q2 | $2.88M | Buy |
23,727
+245
| +1% | +$30.6K | 3.52% | 5 |
|
|
2018
Q1 | $3.01M | Buy |
23,482
+60
| +0.3% | +$8.11K | 3.71% | 3 |
|
|
2017
Q4 | $3.27M | Buy |
23,422
+2,067
| +10% | +$288K | 3.95% | 1 |
|
|
2017
Q3 | $2.78M | Sell |
21,355
-982
| -4% | -$130K | 3.91% | 3 |
|
|
2017
Q2 | $2.96M | Buy |
22,337
+412
| +2% | +$52.6K | 4.24% | 1 |
|
|
2017
Q1 | $2.73M | Buy |
21,925
+1,048
| +5% | +$125K | 4.18% | 1 |
|
|
2016
Q4 | $2.41M | Buy |
20,877
+100
| +0.5% | +$11.6K | 4.22% | 2 |
|
|
2016
Q3 | $2.45M | Buy |
20,777
+75
| +0.4% | +$9.1K | 4.3% | 1 |
|
|
2016
Q2 | $2.51M | Buy |
20,702
+47
| +0.2% | +$5.34K | 4.47% | 1 |
|
|
2016
Q1 | $2.23M | Buy |
20,655
+2,090
| +11% | +$216K | 3.92% | 2 |
|
|
2015
Q4 | $1.91M | Buy |
+18,565
| New | +$1.87M | 3.67% | 3 |
|
Other funds holding JNJ
VCM
VPM
Nancy E. Dempze's JNJ Position: Q1 2026 in Review
Nancy E. Dempze reduced its Johnson & Johnson (JNJ) stake by 0.06% in Q1 2026, selling an estimated $3.03K and leaving 22,097 shares worth $5.4M. The position accounts for 2.97% of the portfolio, ranked #9.
Nancy E. Dempze first reported a position in JNJ in Q4 2015 and has held it in 42 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Nancy E. Dempze held 22,097 shares of Johnson & Johnson worth $5.4M as of Q1 2026.
- Nancy E. Dempze sold 13 Johnson & Johnson shares in Q1 2026, an estimated $3.03K.
- Johnson & Johnson made up 2.97% of Nancy E. Dempze's portfolio in Q1 2026, its #9 holding.
- Nancy E. Dempze first reported a position in Johnson & Johnson in Q4 2015 and has held it in 42 quarters since.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Nancy E. Dempze's 13F filing for Q1 2026, filed 14 May 2026.